Variation in risk and outcomes of Epstein–Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies: an exploratory study

Sally L. Glaser, Alison J. Canchola, Theresa H Keegan, Christina A. Clarke, Teri A. Longacre, Margaret L. Gulley

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: A relationship of Epstein–Barr virus (EBV) and breast cancer etiology and outcome may have clinical utility and potential to enhance understanding of tumor biology. Research to date has yielded variable results, likely reflecting differing virus detection assays and unaddressed epidemiologic heterogeneity across studies. Methods: Applying our novel, five-target assay detection strategy in an exploratory study, we examined demographic, clinical, and tumor characteristics, and overall survival, associated with EBV positivity in breast adenocarcinomas from 59 non-Hispanic white and 68 Hispanic women sampled by age (<50, 50+) and stage (localized, regional/remote) and examined associations based on single assay targets. Results: EBV was localized only to lymphocytes. Nevertheless, viral prevalence, although low, varied across patient subgroups. Adjusted odds ratios (OR) for EBV positivity were lower for younger Hispanic than white women (pinteraction = 0.05), and marginally higher for larger [OR (95% confidence intervals) 1.03 (1.00–1.05) per mm increase] and right-sided [2.8 (0.97–7.8)] tumors. In whites, ORs were marginally higher for larger tumors [1.04 (1.00–1.07)] and marginally lower for age 50+ [0.24 (0.06–1.03)]; in Hispanics, ORs were higher for ER negative [5.6 (1.1–30.5)], and marginally higher for right-sided, tumors [5.8 (0.94–36.2)]. Survival was suggestively poorer for EBV-positive than EBV-negative tumors in older women with localized disease. EBV associations differed across single assay targets, indicating variation in prior findings likely due to assay performance. Conclusions: The differing EBV associations by age and race/ethnicity suggest a non-random role of EBV in breast cancer and support further study using multi-target assays, relevant epidemiologic design, and a larger study sample.

Original languageEnglish (US)
Pages (from-to)273-287
Number of pages15
JournalCancer Causes and Control
Volume28
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Breast Neoplasms
Viruses
Hispanic Americans
Neoplasms
Odds Ratio
Oncogenic Viruses
Survival
Adenocarcinoma
Breast
Demography
Lymphocytes
Confidence Intervals
Research

Keywords

  • Biomarkers
  • Breast cancer
  • Epidemiology
  • Epstein–Barr virus
  • Race/ethnicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Variation in risk and outcomes of Epstein–Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies : an exploratory study. / Glaser, Sally L.; Canchola, Alison J.; Keegan, Theresa H; Clarke, Christina A.; Longacre, Teri A.; Gulley, Margaret L.

In: Cancer Causes and Control, Vol. 28, No. 4, 01.04.2017, p. 273-287.

Research output: Contribution to journalArticle

Glaser, Sally L. ; Canchola, Alison J. ; Keegan, Theresa H ; Clarke, Christina A. ; Longacre, Teri A. ; Gulley, Margaret L. / Variation in risk and outcomes of Epstein–Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies : an exploratory study. In: Cancer Causes and Control. 2017 ; Vol. 28, No. 4. pp. 273-287.
@article{01a272d4e64a42f7b4dbfacdaacb8445,
title = "Variation in risk and outcomes of Epstein–Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies: an exploratory study",
abstract = "Purpose: A relationship of Epstein–Barr virus (EBV) and breast cancer etiology and outcome may have clinical utility and potential to enhance understanding of tumor biology. Research to date has yielded variable results, likely reflecting differing virus detection assays and unaddressed epidemiologic heterogeneity across studies. Methods: Applying our novel, five-target assay detection strategy in an exploratory study, we examined demographic, clinical, and tumor characteristics, and overall survival, associated with EBV positivity in breast adenocarcinomas from 59 non-Hispanic white and 68 Hispanic women sampled by age (<50, 50+) and stage (localized, regional/remote) and examined associations based on single assay targets. Results: EBV was localized only to lymphocytes. Nevertheless, viral prevalence, although low, varied across patient subgroups. Adjusted odds ratios (OR) for EBV positivity were lower for younger Hispanic than white women (pinteraction = 0.05), and marginally higher for larger [OR (95{\%} confidence intervals) 1.03 (1.00–1.05) per mm increase] and right-sided [2.8 (0.97–7.8)] tumors. In whites, ORs were marginally higher for larger tumors [1.04 (1.00–1.07)] and marginally lower for age 50+ [0.24 (0.06–1.03)]; in Hispanics, ORs were higher for ER negative [5.6 (1.1–30.5)], and marginally higher for right-sided, tumors [5.8 (0.94–36.2)]. Survival was suggestively poorer for EBV-positive than EBV-negative tumors in older women with localized disease. EBV associations differed across single assay targets, indicating variation in prior findings likely due to assay performance. Conclusions: The differing EBV associations by age and race/ethnicity suggest a non-random role of EBV in breast cancer and support further study using multi-target assays, relevant epidemiologic design, and a larger study sample.",
keywords = "Biomarkers, Breast cancer, Epidemiology, Epstein–Barr virus, Race/ethnicity",
author = "Glaser, {Sally L.} and Canchola, {Alison J.} and Keegan, {Theresa H} and Clarke, {Christina A.} and Longacre, {Teri A.} and Gulley, {Margaret L.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1007/s10552-017-0865-3",
language = "English (US)",
volume = "28",
pages = "273--287",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Variation in risk and outcomes of Epstein–Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies

T2 - an exploratory study

AU - Glaser, Sally L.

AU - Canchola, Alison J.

AU - Keegan, Theresa H

AU - Clarke, Christina A.

AU - Longacre, Teri A.

AU - Gulley, Margaret L.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Purpose: A relationship of Epstein–Barr virus (EBV) and breast cancer etiology and outcome may have clinical utility and potential to enhance understanding of tumor biology. Research to date has yielded variable results, likely reflecting differing virus detection assays and unaddressed epidemiologic heterogeneity across studies. Methods: Applying our novel, five-target assay detection strategy in an exploratory study, we examined demographic, clinical, and tumor characteristics, and overall survival, associated with EBV positivity in breast adenocarcinomas from 59 non-Hispanic white and 68 Hispanic women sampled by age (<50, 50+) and stage (localized, regional/remote) and examined associations based on single assay targets. Results: EBV was localized only to lymphocytes. Nevertheless, viral prevalence, although low, varied across patient subgroups. Adjusted odds ratios (OR) for EBV positivity were lower for younger Hispanic than white women (pinteraction = 0.05), and marginally higher for larger [OR (95% confidence intervals) 1.03 (1.00–1.05) per mm increase] and right-sided [2.8 (0.97–7.8)] tumors. In whites, ORs were marginally higher for larger tumors [1.04 (1.00–1.07)] and marginally lower for age 50+ [0.24 (0.06–1.03)]; in Hispanics, ORs were higher for ER negative [5.6 (1.1–30.5)], and marginally higher for right-sided, tumors [5.8 (0.94–36.2)]. Survival was suggestively poorer for EBV-positive than EBV-negative tumors in older women with localized disease. EBV associations differed across single assay targets, indicating variation in prior findings likely due to assay performance. Conclusions: The differing EBV associations by age and race/ethnicity suggest a non-random role of EBV in breast cancer and support further study using multi-target assays, relevant epidemiologic design, and a larger study sample.

AB - Purpose: A relationship of Epstein–Barr virus (EBV) and breast cancer etiology and outcome may have clinical utility and potential to enhance understanding of tumor biology. Research to date has yielded variable results, likely reflecting differing virus detection assays and unaddressed epidemiologic heterogeneity across studies. Methods: Applying our novel, five-target assay detection strategy in an exploratory study, we examined demographic, clinical, and tumor characteristics, and overall survival, associated with EBV positivity in breast adenocarcinomas from 59 non-Hispanic white and 68 Hispanic women sampled by age (<50, 50+) and stage (localized, regional/remote) and examined associations based on single assay targets. Results: EBV was localized only to lymphocytes. Nevertheless, viral prevalence, although low, varied across patient subgroups. Adjusted odds ratios (OR) for EBV positivity were lower for younger Hispanic than white women (pinteraction = 0.05), and marginally higher for larger [OR (95% confidence intervals) 1.03 (1.00–1.05) per mm increase] and right-sided [2.8 (0.97–7.8)] tumors. In whites, ORs were marginally higher for larger tumors [1.04 (1.00–1.07)] and marginally lower for age 50+ [0.24 (0.06–1.03)]; in Hispanics, ORs were higher for ER negative [5.6 (1.1–30.5)], and marginally higher for right-sided, tumors [5.8 (0.94–36.2)]. Survival was suggestively poorer for EBV-positive than EBV-negative tumors in older women with localized disease. EBV associations differed across single assay targets, indicating variation in prior findings likely due to assay performance. Conclusions: The differing EBV associations by age and race/ethnicity suggest a non-random role of EBV in breast cancer and support further study using multi-target assays, relevant epidemiologic design, and a larger study sample.

KW - Biomarkers

KW - Breast cancer

KW - Epidemiology

KW - Epstein–Barr virus

KW - Race/ethnicity

UR - http://www.scopus.com/inward/record.url?scp=85013477276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013477276&partnerID=8YFLogxK

U2 - 10.1007/s10552-017-0865-3

DO - 10.1007/s10552-017-0865-3

M3 - Article

C2 - 28229344

AN - SCOPUS:85013477276

VL - 28

SP - 273

EP - 287

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 4

ER -